HCG Beta Subunit, CSF

This test evaluates the levels of a particular substance in your cerebrospinal fluid. The measurement assists in managing trophoblastic and testicular tumours, aiding in diagnosing and treating these types of cancers.

This test is primarily done to:

• Detect and manage trophoblastic or testicular tumours.
• Monitor the effectiveness of treatment for these tumours.
• Assist in the diagnosis and monitoring of conditions impacting HCG levels.
• Assess the risk of developing trophoblastic tumours.

Doctors recommend this test if you:

• Have trophoblastic or testicular tumours.
• Exhibit symptoms suggestive of these tumours or conditions affecting HCG levels.
• Require monitoring during treatment for these tumours.
• We need to assess the risk of developing trophoblastic tumours.

Abnormal results may indicate trophoblastic or testicular tumors. Abnormal results require further evaluation by your healthcare provider for proper diagnosis and treatment.

Your sample will be collected as follows:

• 2 ml of cerebrospinal fluid in a leakproof container
• Use a folin vu conical tube to prevent leakage

Before the test:

• Collect 2 ml of cerebrospinal fluid.
• Use a leakproof container for sample collection.
• Store the sample as per the guidelines.
• Follow any specific instructions provided by your healthcare provider.

• Human Chorionic Gonadotropin (HCG) Testing: Evaluates hormone levels for pregnancy or as a tumour marker.
• Testicular Ultrasound: Assists in detecting abnormalities in the testicles.
• Trophoblastic Tumour Marker Testing: Identifies markers related to trophoblastic tumours.

• CSF HCG Beta Subunit Test 
• Cerebrospinal Fluid Human Chorionic Gonadotropin (HCG) Test

Trophoblastic and testicular tumours are cancerous growths that originate from cells in the placenta or the testicles. These tumours can affect reproductive health and require early diagnosis and appropriate treatment for better outcomes.